J&J | JNJ - مصاريف البيع والإدارة

سعر السهم
227.50
التغيير اليومي
-3.15 -1.37%
شهريا
-5.18%
سنويا
47.17%
Q2 التوقعات
222.63




مصاريف البيع والإدارة تغيير تاريخ
AbbVie USD 3.89B 325M 2025-12
Abbott USD 3.27B 138M 2026-03
Amgen USD 1.94B 237M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Baxter International USD 761M 53M 2025-12
Bayer EUR 4.05B 647M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Biogen USD 545.2M 38.6M 2025-09
Boston Scientific USD 1.83B 93M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
CONMED USD 166.76M 26.42M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Eli Lilly USD 3.13B 391.3M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Globus Medical USD 318.48M 4.88M 2025-12
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Medtronic 2.97B 159M 2025-09
Merck USD 2.85B 215M 2025-12
Merit Medical Systems USD 114.83M 7.45M 2025-12
Novartis USD 3.44B 128M 2025-12
Pfizer USD 4.08B 894M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12
Zoetis USD 619M 40M 2025-12